Concepedia

Affimed Therapeutics (Germany)

AT

203

Publications

30.1K

Citations

37

Authors

Heidelberg

Germany

Affimed Therapeutics (Germany) is a company institution in Heidelberg, Germany known for medicine, immunology, and cell biology.

HomepageROR

Top concepts

Publications

203

Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma

Christopher J. Gibson, R. Coleman Lindsley, Vatche Tchekmedyian et al. · Journal of Clinical Oncology · 2017 · 455 citations · Full text

A phase 1 study of the bispecific anti-CD30/CD16A antibody construct AFM13 in patients with relapsed or refractory Hodgkin lymphoma

Achim Rothe, Stephanie Sasse, Max S. Topp et al. · Blood · 2015 · 320 citations · Full text

A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells

Uwe Reusch, Carmen Burkhardt, Ivica Fucek et al. · mAbs · 2014 · 158 citations · Full text

, , +18

Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood–Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies

Lucila Nassif Kerbauy, Nancy D. Marín, Mecit Kaplan et al. · Clinical Cancer Research · 2021 · 147 citations · Full text

A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

Nancy L. Bartlett, Alex F. Herrera, Eva Domingo‐Doménech et al. · Blood · 2020 · 145 citations · Full text

Rows per page

1–5 of 203

Authors

37

PublicationsCitationsH-Index
UR
Uwe Reusch

Affimed Therapeutics (Germany)

118

2.8K

29

SK
Stefan Knackmuss

Affimed Therapeutics (Germany)

70

1.7K

23

FL
Fabrice Le Gall

Affimed Therapeutics (Germany)

23

1.3K

17

KE
Kristina Ellwanger

Affimed Therapeutics (Germany)

56

1.3K

16

MT
Martin Treder

Affimed Therapeutics (Germany)

124

947

15

Rows per page

1–5 of 37